loader image
Sunday, December 14, 2025
62.2 F
McAllen
- Advertisement -

From Mild Cognitive Impairment to Alzheimer’s 

Translate to Spanish or other 102 languages!

How can we predict who will progress to Alzheimer’s from mild cognitive impairment. Image for illustration purposes
How can we predict who will progress to Alzheimer’s from mild cognitive impairment. Image for illustration purposes

Medical News Today

- Advertisement -
  • Dementia affects more than 55 million people worldwide, costing around $1.3 trillion per year.
  • The most common form of dementia, Alzheimer’s disease, affects up to 70% of these people.
  • New treatments are most effective if started early in the progression of the disease, but diagnosis is difficult at this stage as early symptoms are often dismissed as normal changes due to aging.
  • Now, a new study has developed a deep learning framework that can identify the risk of progressing from mild cognitive impairment to Alzheimer’s.

In 2019, according to the Global Burden of Diseases, Injuries, and Risk Factors StudyTrusted Source, an estimated 57.4 million people worldwide had dementia.

Follow the link below to read the entire article on Medical News Today: 

https://www.medicalnewstoday.com/articles/from-mild-cognitive-impairment-to-alzheimers-predicting-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Tips to Tame the ‘Sunday Scaries’

Weekends only last so long, and if you start feeling anxious by Sunday, you're not alone.

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

Off-the-Shelf Immunotherapy Offers Hope for Aggressive Myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. 

FDA Approves Zenflow Spring® System for BPH Treatment

 Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
- Advertisement -
×